Provided by Tiger Trade Technology Pte. Ltd.

BIOCYTOGEN-B

51.750
-0.850-1.62%
Volume:163.50K
Turnover:8.79M
Market Cap:23.13B
PE:614.07
High:56.800
Open:52.600
Low:51.700
Close:52.600
52wk High:63.000
52wk Low:7.710
Shares:447.00M
HK Float Shares:111.00M
Volume Ratio:0.18
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.084
ROE:16.11%
ROA:6.20%
PB:22.85
PE(LYR):614.07
PS:17.11

Loading ...

BIOCYTOGEN-B Appoints Liu Hongkang as Non-Executive Director

Stock News
·
Feb 12

BIOCYTOGEN-B Shares Surge Over 6% on Strong 2025 Forecast and Licensing Deals

Stock News
·
Feb 11

BIOCYTOGEN-B Shares Surge Over 5% Again on Strong Core Business Performance and Institutional Optimism

Stock News
·
Feb 04

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315) Announces January 2026 Share Capital and Public Float Update

Bulletin Express
·
Feb 03

BIOCYTOGEN-B (02315) Surges Over 10% Again, Forecasts Up to 4.4-Fold Annual Net Profit Growth on Multiple Major Out-Licensing Deals

Stock News
·
Feb 03

BIOCYTOGEN-B (02315) Surges Nearly 13% After Profit Alert; Forecasts 40% Revenue Growth and 400% Net Profit Jump for Full Year

Stock News
·
Jan 30

Hong Kong Stock Announcement Highlights | Muyuan Foods Launches Hong Kong IPO; Sunny Optical Expects 2025 Net Profit to Surge 70%-75%

Stock News
·
Jan 29

Biocytogen Pharmaceuticals Expects Upto 444% Higher Profit in 2025

MT Newswires Live
·
Jan 29

BIOCYTOGEN-B (02315) Issues 2025 Performance Forecast: Expects Net Profit Attributable to Owners of RMB162 Million to RMB182 Million, Up 384.26% to 443.88% YoY

Stock News
·
Jan 29

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Stock Code: 2315) Announces Estimated 2025 Annual Results

Bulletin Express
·
Jan 29

Biocytogen Pharmaceuticals to Raise Capital in Subsidiary by 550 Million Yuan

MT Newswires Live
·
Jan 28

BIOCYTOGEN-B (02315) Plans to Use Idle Own Funds for Cash Management

Stock News
·
Jan 28

Biocytogen-B (02315) Proposes Appointment of Liu Hongkang as Non-Executive Director

Stock News
·
Jan 27

GTHT Securities: Initiates Coverage on BIOCYTOGEN-B (02315) with "Add" Rating; "Antibody Shelf" Reshapes Drug R&D Ecosystem

Stock News
·
Jan 26

BIOCYTOGEN-B (02315) Rises Nearly 7% Again, Completes Localized Deployment of AI-Driven Antibody Drug R&D Platform

Stock News
·
Jan 21

BIOCYTOGEN-B Surges Over 12% in Intraday Trading, Completes Localized Deployment of AI-Driven Antibody Drug Development Platform

Deep News
·
Jan 14

Zhytong Hong Kong Market Analysis | Geopolitical Concerns Drive Many Gold Stocks to Record Highs; Positive News Boosts CXO Sector

Stock News
·
Jan 13

Biocytogen Pharma Expands ADC Collaboration with Acepodia; Shares Rise 9%

MT Newswires Live
·
Jan 13

BIOCYTOGEN-B (02315) Enters Further Collaboration with Acepodia via Option-Based Evaluation Framework to Advance First-in-Class Bispecific Antibody Dual-Drug Conjugate Program

Stock News
·
Jan 12

BIOCYTOGEN-B (02315) Surges Nearly 10% Intraday, Hitting New Listing High Following Expanded Collaboration With Acepodia

Stock News
·
Jan 12